Leon V. Berhardt 
Advances in Medicine and Biology. Volume 164 

Advances in Medicine and Biology. Volume 164 begins by proposing that first-line chemotherapy of metastatic colorectal cancer consensus molecular subtypes appears to be a prognostic factor that is able to provide information about growth rate. The authors go on to review the current and future applications of bioartificial grafts and conduits in the bridging of peripheral nerve defects. Ginsenoside Rb1 and phosphoramidon are studied in the zebrafish model of diabetic retinopathy, a progressive proliferative and non-proliferative disorder of retina with alterations of the blood-retinal barrier. Basic knowledge on the events from follicle development to implantation crucial to achieve successful conception as well as contraception is presented, describing the mechanism of contraceptive action of Chhaya. Hydroxydaunorubicin, also known as doxorubicin, a metabolite of Streptomyces peucetius and a prominent family member of anthracycline antibiotics is studied. The authors also review the possible mechanisms by which doxorubicin provokes concomitant side effects and clinical disorders, as well as the damage-assaying biochemical markers and the metabolites in these conditions. Updated data with a systematic search through the largest medical information databases is used to assess the therapeutic and preventive role in urinary incontinence of pelvic floor rehabilitation in pregnancy and postpartum. In closing, recent studies on the host and lactic acid bacteria as well as probiotic interactions in terms of molecular and cellular mechanisms of action via signaling pathways, apoptosis, and heat shock proteins are reviewed.